semaglutide deadline ⚠️ Important Patient Update: Ordering ⚠️ Please note that October 14th will be the last day to order compounded semaglutide through Headwaters. After this date, patients who wish to continue Compounded Semaglutide: FDA 2026 Rule

Retatrutide: still in clinical trials Retatrutide has not received FDA approval for any indication

Clinical markers tell the story: if ALT or AST liver enzymes rise above 40 U/L during semaglutide therapy, or if fatigue becomes limiting despite adequate sleep and hydration, lipotropic support is mechanistically justified

Rather than increasing medication on a fixed schedule, Nooms physician-approved and designed protocol adjusts dosing based on each patients individual progress and response

High-sugar diets May interfere with glutathione absorption

This choice doesn't affect your price: your dose may need to go up, but your monthly cost stays the same